Spatz, Erica S.

Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project)

Lu, J., Lu, Y., Wang, X., Li, X., Linderman, G. C., Wu, C., Cheng, X., Mu, L., Zhang, H., Liu, J., et al. (2017) · The Lancet

Blood Pressure and Hypertension StudiesSodium Intake and Health

Cited by 1,133

Psychological Health, Well-Being, and the Mind-Heart-Body Connection: A Scientific Statement From the American Heart Association

Levine, G. N., Cohen, B. E., Commodore-Mensah, Y., Fleury, J., Huffman, J. C., Khalid, U., Labarthe, D. R., Lavretsky, H., Michos, E. D., Spatz, E. S., et al. (2021) · Circulation

Cardiac Health and Mental HealthCardiovascular Health and Risk Factors

Cited by 865

National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013: Insights From the Medical Expenditure Panel Survey

Salami, J. A., Warraich, H., Valero-Elizondo, J., Spatz, E. S., Desai, N. R., Rana, J. S., Virani, S. S., Blankstein, R., Khera, A., Blaha, M. J., et al. (2017) · JAMA Cardiology

Lipoproteins and Cardiovascular HealthPharmaceutical Economics and Policy

Cited by 370

2020 ACC/AHA guideline for the management of patients with valvular heart disease

Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · The Journal of Thoracic and Cardiovascular Surgery

Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment Approaches

Cited by 279

A Systematic Review of the Prevalence and Outcomes of Ideal Cardiovascular Health in US and Non-US Populations

Younus, A., Aneni, E. C., Spatz, E. S., Osondu, C. U., Roberson, L., Ogunmoroti, O., Malik, R., Ali, S. S., Aziz, M., Feldman, T., et al. (2016) · Mayo Clinic Proceedings

Cardiovascular Health and Risk FactorsHealth Promotion and Cardiovascular Prevention

Cited by 252

The New Era of Informed Consent: Getting to a Reasonable-Patient Standard Through Shared Decision Making

Spatz, E. S., Krumholz, H. M., & Moulton, B. W. (2016) · JAMA

Ethics and bioethics in healthcarePatient-Provider Communication in Healthcare

Cited by 236

Prime time for shared decision making

Spatz, E. S., Krumholz, H. M., & Moulton, B. W. (2017) · JAMA

Patient-Provider Communication in HealthcarePalliative Care and End-of-Life Issues

Cited by 173

Favorable Cardiovascular Risk Profile Is Associated With Lower Healthcare Costs and Resource Utilization: The 2012 Medical Expenditure Panel Survey

Valero-Elizondo, J., Salami, J. A., Ogunmoroti, O., Osondu, C. U., Aneni, E. C., Malik, R., Spatz, E. S., Rana, J. S., Virani, S. S., Blankstein, R., et al. (2016) · Circulation: Cardiovascular Quality and Outcomes

Cardiovascular Health and Risk FactorsHealth Promotion and Cardiovascular Prevention

Cited by 51

Moving Beyond the Model

Jain, S. S., Mortazavi, B. J., Chan You, S., Yao, X., Lam, C. S. P., Elias, P., Poterucha, T. J., Avram, R., Tison, G. H., Pirruccello, J., et al. (2025) · JACC

Clinical practice guidelines implementationHealth and Medical Research Impacts

Cited by 13

Favorable cardiovascular risk factor profile is associated with lower healthcare expenditure and resource utilization among adults with diabetes mellitus free of established cardiovascular disease: 2012 Medical Expenditure Panel Survey (MEPS)

Feldman, D. I., Valero-Elizondo, J., Salami, J. A., Rana, J. S., Ogunmoroti, O., Osondu, C. U., Spatz, E. S., Virani, S. S., Blankstein, R., Blaha, M. J., et al. (2017) · Atherosclerosis

Diabetes, Cardiovascular Risks, and LipoproteinsHealth Promotion and Cardiovascular Prevention

Cited by 11